Chemins, Company Exec Indicted On Misbranding, Conspiracy Charges
This article was originally published in The Tan Sheet
Executive Summary
The founder and president of Chemins, a Colorado-based dietary supplement manufacturer, is expected to enter a plea Nov. 8 on federal charges of product misbranding, conspiracy and obstructing FDA's investigation into the firm's alleged use of pharmaceutical-grade ephedrine and caffeine in its products.